Actively Recruiting

Phase 2
Age: 55Years +
MALE
ID04301765

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Led by Seattle Institute for Biomedical and Clinical Research · Updated on 2026-03-31

230

Participants Needed

3

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of testosterone replacement therapy on cancer-related fatigue, sexual dysfunction, and quality of life in men aged 55 years and older who have solid or blood cancers and low testosterone levels. This large randomized, double-blind, placebo-controlled trial aims to determine if 6 months of testosterone gel application can improve these symptoms in men who report fatigue and have testosterone deficiency. Participants will be randomly assigned to receive either testosterone 1.62% gel or a placebo gel, both applied daily at home for 6 months. All participants will receive training and printed instructions on how to apply the gel. The study includes five visits: screening, baseline, a 2-week dose adjustment, a 3-month visit, and a 6-month visit. During the study, participants will be monitored for changes in fatigue and sexual activity scores over 6 months. Researchers will conduct assessments at each visit, including blood tests to measure testosterone levels and other health markers. The trial also tracks body composition and muscle function, ensuring participant safety and treatment adherence throughout the study period.

CONDITIONS

Brief Title

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Who Can Participate

Age: 55Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Men with active solid or blood cancers who have received or are receiving chemotherapy or radiation therapy and are within 60 months of their last treatment
  • Age 55 years and older
  • Life expectancy of at least 6 months
  • Low serum testosterone (<348 ng/dl) or low free testosterone (<70 pg/ml) measured by mass spectrometry
  • Fatigue defined as a FACIT-Fatigue subscale score less than 40
  • Ability and willingness to provide informed consent
Not Eligible

You will not qualify if you...

  • History of prostate, breast, testicular, or adrenal cancers
  • Use of anabolic agents such as testosterone, DHEA, or growth hormone within the past 6 months
  • Hematocrit greater than 48% or serum creatinine over 2.5 mg/dL
  • PSA over 4 ng/ml or abnormal digital rectal exam findings
  • Severe untreated sleep apnea
  • Uncontrolled congestive heart failure
  • Recent heart attack, stroke, or thromboembolism within 6 months
  • Known genetic thrombophilia
  • Previous stroke with lasting cognitive or functional deficits
  • Inability to provide informed consent or MMSE score less than 24
  • Poorly controlled diabetes with hemoglobin A1c over 10.0%
  • Body mass index over 40 kg/m2
  • Diagnosis of bipolar disorder or schizophrenia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Run-in Period

Duration - Up to 2 weeks

Participants learn how to apply the testosterone or placebo gel daily at home and start baseline assessments.

1 baseline visit

Treatment

Duration - 6 months

Participants apply testosterone or placebo gel daily at home for 6 months to assess effects on fatigue, sexual function, body composition, and muscle function.

4 visits (Baseline, 2-week dose adjustment, 3-month, and 6-month visits)

Trial Site Locations

Total: 3 locations

1

Georgia Cancer Center at Augusta University

Augusta, Georgia, United States, 30912

Actively Recruiting

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

3

Veterans Affairs Puget Sound Health Care System

Seattle, Washington, United States, 98108

Actively Recruiting

Loading map...

Research Team

J

Jose Garcia, MD, Phd

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Functional Assessment of Balance and Gait and Correlation Wi...

Multiple Sclerosis

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here